Active Substance & Generic Molecule Directory
Bifidobacterium Lactis in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Bifidobacterium Lactis registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
10
Registered Brands
Availability in Malaysia:1 Over-The-Counter (MAL-X)9 Supplements (MAL-N)
Showing 10 of 10 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL22066083NC | ALTERFLOR BB PROBIOTIC WITH FOS POWDER | 0.0034gm 2.000 gm | Health Supplement (MAL-N) | BIO INTEGRUM SDN BHD | Compare → |
| MAL19126101N | ASTAR PROBIOTICS PLUS POWDER | 62.5 mg 2000 gm | Health Supplement (MAL-N) | GN NEUTRICEUTICALS SDN. BHD. | Compare → |
| MAL26046081NC | GKB Biomelac Capsule | 250 mg 480 mg | Health Supplement (MAL-N) | GK BIO INTERNATIONAL SDN. BHD. | Compare → |
| MAL25126099NC | GKB Faiirmor Capsule | 100 mg 400 mg | Health Supplement (MAL-N) | GK BIO INTERNATIONAL SDN. BHD. | Compare → |
| MAL12055046N | Melaleuca FLORIFY | 4.444mg 340.369mg | Health Supplement (MAL-N) | Melaleuca Southeast Asia (malaysia) Sdn. Bhd. | Compare → |
| MAL08120907XC | PROBiO LACT ACTIVE FORMULA 10 BILLION | 67 mg 470 mg | OTC (MAL-X) | EUROBIO SDN BHD | Compare → |
| MAL22026061NC | StemLabs PROFLORABIO CAPSULE | 23.53 mg 500 mg | Health Supplement (MAL-N) | CELLGEN LIFESCIENCES (M) SDN. BHD. | Compare → |
| MAL22116059N | VITASEN PRO-BIOS Probiotics 10B Capsule | 8.16 mg 400 mg | Health Supplement (MAL-N) | WINWA MEDICAL SDN. BHD. | Compare → |
| MAL15015042N | VITASEN PRO-BIOS Probiotics Capsule | 66.6mg 400mg | Health Supplement (MAL-N) | WINWA MEDICAL SDN. BHD. | Compare → |
| MAL20026115N | YL Probios ImmuGuz Capsule | 25.30 mg 460.00 mg | Health Supplement (MAL-N) | YANLING NATURAL HYGIENE SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.